Search

Diana B. Johannsen

Examiner (ID: 9339, Phone: (571)272-0744 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1682, 1655
Total Applications
1005
Issued Applications
399
Pending Applications
208
Abandoned Applications
415

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10208797 [patent_doc_number] => 20150093787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR USE IN RECOMBINATIONAL CLONING OF NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 14/452517 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 253 [patent_figures_cnt] => 253 [patent_no_of_words] => 55759 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14452517 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/452517
COMPOSITIONS AND METHODS FOR USE IN RECOMBINATIONAL CLONING OF NUCLEIC ACIDS Aug 4, 2014 Abandoned
Array ( [id] => 11004178 [patent_doc_number] => 20160201127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-14 [patent_title] => 'METHODS AND PROBES FOR MONITORING MARINE WATER' [patent_app_type] => utility [patent_app_number] => 14/909075 [patent_app_country] => US [patent_app_date] => 2014-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7959 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14909075 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/909075
Methods and probes for monitoring marine water Jul 27, 2014 Issued
Array ( [id] => 10282084 [patent_doc_number] => 20150167081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'METHODS OF ASSESSING THE RISK OF REPRODUCTIVE FAILURE BY MEASURING TELOMERE LENGTH' [patent_app_type] => utility [patent_app_number] => 14/323638 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13094 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323638 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/323638
METHODS OF ASSESSING THE RISK OF REPRODUCTIVE FAILURE BY MEASURING TELOMERE LENGTH Jul 2, 2014 Abandoned
Array ( [id] => 10247756 [patent_doc_number] => 20150132752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'METHOD FOR DETERMINING HLA-A*24 GROUP' [patent_app_type] => utility [patent_app_number] => 14/315806 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8011 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315806 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/315806
METHOD FOR DETERMINING HLA-A*24 GROUP Jun 25, 2014 Abandoned
Array ( [id] => 9806582 [patent_doc_number] => 20150018527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY' [patent_app_type] => utility [patent_app_number] => 14/307708 [patent_app_country] => US [patent_app_date] => 2014-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28027 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14307708 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/307708
Methods and materials for assessing loss of heterozygosity Jun 17, 2014 Issued
Array ( [id] => 10961404 [patent_doc_number] => 20140364434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'Biomarkers for Prediction of Response to PARP Inhibition in Breast Cancer' [patent_app_type] => utility [patent_app_number] => 14/298849 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 34443 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298849 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/298849
Biomarkers for Prediction of Response to PARP Inhibition in Breast Cancer Jun 5, 2014 Abandoned
Array ( [id] => 11507592 [patent_doc_number] => 09598739 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-03-21 [patent_title] => 'Human erythrovirus' [patent_app_type] => utility [patent_app_number] => 14/288691 [patent_app_country] => US [patent_app_date] => 2014-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 18449 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14288691 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/288691
Human erythrovirus May 27, 2014 Issued
Array ( [id] => 13805353 [patent_doc_number] => 10179938 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-15 [patent_title] => Artificial selection method and reagents [patent_app_type] => utility [patent_app_number] => 14/245334 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28114 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 430 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245334 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/245334
Artificial selection method and reagents Apr 3, 2014 Issued
Array ( [id] => 10686254 [patent_doc_number] => 20160032400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 14/776412 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 32491 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776412 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/776412
METHOD FOR THE PROGNOSIS AND TREATMENT OF CANCER METASTASIS Mar 13, 2014 Abandoned
Array ( [id] => 9932047 [patent_doc_number] => 20150080239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-19 [patent_title] => 'Classification and Actionability Indices for Cancer' [patent_app_type] => utility [patent_app_number] => 14/212717 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23561 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212717 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/212717
Classification and Actionability Indices for Cancer Mar 13, 2014 Abandoned
Array ( [id] => 10687364 [patent_doc_number] => 20160033509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER' [patent_app_type] => utility [patent_app_number] => 14/775229 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6065 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775229 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/775229
DIAGNOSTIC AND PROGNOSTIC MARKER FOR PROSTATE CANCER Mar 13, 2014 Abandoned
Array ( [id] => 9757418 [patent_doc_number] => 20140288116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'Classification and Actionability Indices for Lung Cancer' [patent_app_type] => utility [patent_app_number] => 14/212115 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212115 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/212115
Classification and Actionability Indices for Lung Cancer Mar 13, 2014 Abandoned
Array ( [id] => 10694101 [patent_doc_number] => 20160040247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 14/776453 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27788 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776453 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/776453
METHOD FOR THE DIAGNOSIS, PROGNOSIS, AND TRATMENT OF CANCER METASTASIS Mar 13, 2014 Abandoned
Array ( [id] => 10912186 [patent_doc_number] => 20140315199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER' [patent_app_type] => utility [patent_app_number] => 14/214300 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 68000 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14214300 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/214300
GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER Mar 13, 2014 Abandoned
Array ( [id] => 10911774 [patent_doc_number] => 20140314792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 14/213670 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 27687 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14213670 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/213670
METHOD FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER METASTASIS Mar 13, 2014 Abandoned
Array ( [id] => 9793240 [patent_doc_number] => 20150005184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS' [patent_app_type] => utility [patent_app_number] => 14/208155 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30032 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208155 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/208155
DIAGNOSIS OF MELANOMA BY NUCLEIC ACID ANALYSIS Mar 12, 2014 Abandoned
Array ( [id] => 10678437 [patent_doc_number] => 20160024583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'METHODS FOR EVALUATING COPD STATUS' [patent_app_type] => utility [patent_app_number] => 14/775379 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12063 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775379 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/775379
Methods for evaluating COPD status Mar 12, 2014 Issued
Array ( [id] => 10954550 [patent_doc_number] => 20140357573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-04 [patent_title] => 'PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA' [patent_app_type] => utility [patent_app_number] => 14/210124 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13359 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14210124 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/210124
PROGNOSTIC ASSAY FOR SQUAMOUS CELL LUNG CARCINOMA Mar 12, 2014 Abandoned
Array ( [id] => 10678441 [patent_doc_number] => 20160024587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'MARKERS ASSOCIATED WITH WNT INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/774212 [patent_app_country] => US [patent_app_date] => 2014-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18004 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 39 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774212 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/774212
Markers associated with Wnt inhibitors Mar 9, 2014 Issued
Array ( [id] => 9771104 [patent_doc_number] => 20140294768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'RESPONSIVENESS TO ANGIOGENESIS INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/191040 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19371 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191040 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/191040
RESPONSIVENESS TO ANGIOGENESIS INHIBITORS Feb 25, 2014 Abandoned
Menu